Relevance of feline interferon omega for clinical improvement and reduction of concurrent viral excretion in retrovirus infected cats from a rescue shelter

Research in Veterinary Science

Volumn 94, Issue 3, 2013, Pages 753-763

  Gil, Solange ^a   Leal, Rodolfo O ^a   Duarte, Ana ^a   McGahie, David ^b   Sepúlveda, Nuno ^c,d   Siborro, Inês ^a   Cravo, Joana ^a   Cartaxeiro, Clara ^a   Tavares, Luís M ^a  

^a FACULDADE DE MEDICINA VETERINÁRIA   (Portugal)

^b Virbac SA   (France)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d Center of Statistics Applications of Lisbon University CEAUL   (Portugal)

Author keywords

Feline calicivirus; Feline coronavirus; Feline herpesvirus; Feline immunodeficiency virus; Feline Leukemia Virus; Interferon; Shelter; Therapy

Indexed keywords

AMOXICILLIN; ANTIVIRUS AGENT; FELINE INTERFERON OMEGA; SILYMARIN; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID; VIRBAGEN OMEGA;

ANEMIA; ANTIVIRAL THERAPY; ARTICLE; CALICIVIRUS; CAT DISEASE; COMORBIDITY; CONTROLLED STUDY; CORONAVIRUS; DOMESTIC ANIMAL; EYE DISCHARGE; EYE MALFORMATION; FELINE IMMUNODEFICIENCY VIRUS; FELINE IMMUNODEFICIENCY VIRUS INFECTION; FELINE LEUKEMIA; FELINE LEUKEMIA VIRUS; FEMALE; FLUID THERAPY; GINGIVITIS; HERPES SIMPLEX VIRUS 1; LYMPHADENOPATHY; MALE; MOUTH ULCER; MUCOSAL DISEASE; NONHUMAN; NOSE DISEASE; PARVOVIRUS; SCORING SYSTEM; SEBORRHEA; STOMATITIS; VIRUS DETECTION; VIRUS LOAD;

ANIMALS; CATS; COINFECTION; CORONAVIRUS, FELINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; FELINE INFECTIOUS PERITONITIS; FELINE PANLEUKOPENIA; FELINE PANLEUKOPENIA VIRUS; FEMALE; IMMUNODEFICIENCY VIRUS, FELINE; INTERFERON TYPE I; LEUKEMIA VIRUS, FELINE; LEUKEMIA, FELINE; MALE; RECOMBINANT PROTEINS;

CALICIVIRIDAE; FELID HERPESVIRUS 1; FELIDAE; FELINE CALICIVIRUS; FELINE CORONAVIRUS; FELINE IMMUNODEFICIENCY VIRUS; FELINE LEUKEMIA VIRUS; HERPESVIRIDAE; PARVOVIRUS;

EID: 84876157116     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2012.09.025     Document Type: Article

References (41)

1. Addie D., Belak S., Boucraut-Baralon C., Egberink H., Frymus T., Gruffydd-Jones T., Hartmann K., Hosie M.J., Lloret A., Lutz H., Marsilio F., Pennisi M.G., Radford A.D., Thiry E., Truyen U., Horzinek M.C. Feline infectious peritonitis. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery 2009, 11:594-604.
2. Caney, S., Helps,C., Finerty, S., Tasker, S., Gruffydd-Jones, TJ. 2003. Treatment of asymptomatic chronically FIV-infected cats with recombinant feline interferon omega. In: Proceedings of the Annual Conference of the American College of Veterinary Internal Medicine, Charlotte, USA.
3. Clegg S.R., Coyne K.P., Dawson S., Spibey N., Gaskell R.M., Radford A.D. Canine parvovirus in asymptomatic feline carriers. Vet Microbiology 2011, 157:78-85.
4. Collado V.M., Doménech A., Gómez-Lucía E., Tejerizo G., Miró G. Usos de interferón en la clínica de pequeños animales. Pequeños animales 2006, 63:68-75.
5. de Mari K., Maynard L., Sanquer A., Lebreux B., Eun H.M. Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats. Journal of Veterinary Internal Medicine 2004, 18:477-482.
6. Desario C., Decaro N., Campolo M., Cavalli A., Cirone F., Elia G., Martella V., Lorusso E., Camero M., Buonavoglia C. Canine parvovirus infection: which diagnostic test for virus?. Journal of Virological Methods 2005, 126:179-185.
7. Domenech A., Miro G., Collado V.M., Ballesteros N., Sanjose L., Escolar E., Martin S., Gomez-Lucia E. Use of recombinant interferon omega in feline retrovirosis: from theory to practice. Veterinary Immunology and Immunopathology 2011, 143:301-306.
8. Dowers K.L., Hawley J.R., Brewer M.M., Morris A.K., Radecki S.V., Lappin M.R. Association of Bartonella species, feline calicivirus, and feline herpesvirus 1 infection with gingivostomatitis in cats. Journal of Feline Medicine and Surgery 2010, 12:314-321.
9. Duarte A., Veiga I., Tavares L. Genetic diversity and phylogenetic analysis of Feline Coronavirus sequences from Portugal. Veterinary Microbiology 2009, 138:163-168.
10. Dunham S.P., Graham E. Retroviral infections of small animals. Veterinary Clinics of North America Small Animal Practice 2008, 38(ix):879-901.
11. Fogle J.E., Tompkins W.A., Campbell B., Sumner D., Tompkins M.B. Fozivudine tidoxil as single-agent therapy decreases plasma and cell-associated viremia during acute feline immunodeficiency virus infection. Journal of Veterinary Internal Medicine 2011, 25:413-418.
12. Foley J.E., Poland A., Carlson J., Pedersen N.C. Patterns of feline coronavirus infection and fecal shedding from cats in multiple-cat environments. Journal of American Veterinary Medical Association 1997, 210:1307-1312.
13. Gerlach N., Gibbert K., Alter C., Nair S., Zelinskyy G., James C.M., Dittmer U. Anti-retroviral effects of type I IFN subtypes in vivo. European Journal of Immunology 2009, 39:136-146.
14. Gerlach N., Schimmer S., Weiss S., Kalinke U., Dittmer U. Effects of type I interferons on Friend retrovirus infection. Journal of Virology 2006, 80:3438-3444.
15. Gleich S., Hartmann K. Hematology and serum biochemistry of feline immunodeficiency virus-infected and feline leukemia virus-infected cats. Journal of Veterinary Internal Medicine 2009, 23:552-558.
16. Gleich S.E., Krieger S., Hartmann K. Prevalence of feline immunodeficiency virus and feline leukaemia virus among client-owned cats and risk factors for infection in Germany. Journal of Feline Medicine and Surgery 2009, 11:985-992.
17. Hartmann K. Clinical aspects of feline immunodeficiency and feline leukemia virus infection. Veterinary Immunology and Immunopathology 2011, 143:190-201.
18. Hennet, P., Boucraut-Baralon C. 2005. Relationship between oral calicivirus and herpesvirus carriage and palatoglossitis. In: Proceedings of the Nineteenth Annual Veterinary Dental Forum, Orlando, USA.
19. Hennet P.R., Camy G.A., McGahie D.M., Albouy M.V. Comparative efficacy of a recombinant feline interferon omega in refractory cases of calicivirus-positive cats with caudal stomatitis: a randomised, multi-centre, controlled, double-blind study in 39 cats. Journal of Feline Medicine and Surgery 2011, 13:577-587.
20. Herrewegh A.A., de Groot R.J., Cepica A., Egberink H.F., Horzinek M.C., Rottier P.J. Detection of feline coronavirus RNA in feces, tissues, and body fluids of naturally infected cats by reverse transcriptase PCR. Journal of Clinical Microbiology 1995, 33:684-689.
21. Hosie M.J., Addie D., Belak S., Boucraut-Baralon C., Egberink H., Frymus T., Gruffydd-Jones T., Hartmann K., Lloret A., Lutz H., Marsilio F., Pennisi M.G., Radford A.D., Thiry E., Truyen U., Horzinek M.C. Feline immunodeficiency. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery 2009, 11:575-584.
22. Ishida T., Shibanai A., Tanaka S., Uchida K., Mochizuki M. Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis. Journal of Feline Medicine and Surgery 2004, 6:107-109.
23. Lutz H., Addie D., Belak S., Boucraut-Baralon C., Egberink H., Frymus T., Gruffydd-Jones T., Hartmann K., Hosie M.J., Lloret A., Marsilio F., Pennisi M.G., Radford A.D., Thiry E., Truyen U., Horzinek M.C. Feline leukaemia. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery 2009, 11:565-574.
24. Meli M., Kipar A., Muller C., Jenal K., Gonczi E., Borel N., Gunn-Moore D., Chalmers S., Lin F., Reinacher M., Lutz H. High viral loads despite absence of clinical and pathological findings in cats experimentally infected with feline coronavirus (FCoV) type I and in naturally FCoV-infected cats. Journal of Feline Medicine and Surgery 2004, 6:69-81.
25. Muller D. Interferon therapy in dogs and cats. Kleintiermedizin 2002, 8:334-337.
26. Murray J.K., Roberts M.A., Skillings E., Morrow L.D., Gruffydd-Jones T.J. Risk factors for feline immunodeficiency virus antibody test status in Cats Protection adoption centres (2004). Journal of Feline Medicine and Surgery 2009, 11:467-473.
27. Norris J.M., Bell E.T., Hales L., Toribio J.A., White J.D., Wigney D.I., Baral R.M., Malik R. Prevalence of feline immunodeficiency virus infection in domesticated and feral cats in eastern Australia. Journal of Feline Medicine and Surgery 2007, 9:300-308.
28. Paltrinieri S., Crippa A., Comerio T., Angioletti A., Roccabianca P. Evaluation of inflammation and immunity in cats with spontaneous parvovirus infection: consequences of recombinant feline interferon-omega administration. Veterinary Immunology and Immunopathology 2007, 118:68-74.
29. Pardi D., Hoover E.A., Quackenbush S.L., Mullins J.I., Callahan G.N. Selective impairment of humoral immunity in feline leukemia virus-induced immunodeficiency. Veterinary Immunology and Immunopathology 1991, 28:183-200.
30. Pedretti E., Passeri B., Amadori M., Isola P., Di Pede P., Telera A., Vescovini R., Quintavalla F., Pistello M. Low-dose interferon-alpha treatment for feline immunodeficiency virus infection. Veterinary Immunology and Immunopathology 2006, 109:245-254.
31. Pestka S., Krause C.D., Walter M.R. Interferons, interferon-like cytokines, and their receptors. Immunological Reviews 2004, 202:8-32.
32. Radford A.D., Addie D., Belak S., Boucraut-Baralon C., Egberink H., Frymus T., Gruffydd-Jones T., Hartmann K., Hosie M.J., Lloret A., Lutz H., Marsilio F., Pennisi M.G., Thiry E., Truyen U., Horzinek M.C. Feline calicivirus infection. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery 2009, 11:556-564.
33. Reche A., Daniel A.G., Lazaro Strauss T.C., Taborda C.P., Vieira Marques S.A., Haipek K., Oliveira L.J., Monteiro J.M., Kfoury J.R. Cutaneous mycoflora and CD4:CD8 ratio of cats infected with feline immunodeficiency virus. Journal of Feline Medicine and Surgery 2010, 12:355-358.
34. Ritz S., Egberink H., Hartmann K. Effect of feline interferon-omega on the survival time and quality of life of cats with feline infectious peritonitis. Journal of Veterinary Internal Medicine 2007, 21:1193-1197.
35. Tenorio A.P., Franti C.E., Madewell B.R., Pedersen N.C. Chronic oral infections of cats and their relationship to persistent oral carriage of feline calici-, immunodeficiency, or leukemia viruses. Veterinary Immunology and Immunopathology 1991, 29:1-14.
36. Thiry E., Addie D., Belak S., Boucraut-Baralon C., Egberink H., Frymus T., Gruffydd-Jones T., Hartmann K., Hosie M.J., Lloret A., Lutz H., Marsilio F., Pennisi M.G., Radford A.D., Truyen U., Horzinek M.C. Feline herpesvirus infection. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery 2009, 11:547-555.
37. Tompkins W.A. Immunomodulation and therapeutic effects of the oral use of interferon-alpha: mechanism of action. Journal of Interferon & Cytokine Research 1999, 19:817-828.
38. Truyen U., Addie D., Belak S., Boucraut-Baralon C., Egberink H., Frymus T., Gruffydd-Jones T., Hartmann K., Hosie M.J., Lloret A., Lutz H., Marsilio F., Pennisi M.G., Radford A.D., Thiry E., Horzinek M.C. Feline panleukopenia. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery 2009, 11:538-546.
39. Weiss R.C., Cummins J.M., Richards A.B. Low-dose orally administered alpha interferon treatment for feline leukemia virus infection. Journal of American Veterinary Medical Association 1991, 199:1477-1481.
40. Wilhelm S., Truyen U. Real-time reverse transcription polymerase chain reaction assay to detect a broad range of feline calicivirus isolates. Journal of Virological Methods 2006, 133:105-108.
41. Zeidner N.S., Myles M.H., Mathiason-DuBard C.K., Dreitz M.J., Mullins J.I., Hoover E.A. Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome. Antimicrobial Agents and Chemotherapy 1990, 34:1749-1756.